118 related articles for article (PubMed ID: 3007156)
1. Leukocyte activation in advanced cancer as an explanation for absent leukocyte adherence inhibition to cancer extracts and chemoattractant.
Labateya N; Thomson DM; Reid EC
Eur J Cancer Clin Oncol; 1986 Jan; 22(1):33-43. PubMed ID: 3007156
[TBL] [Abstract][Full Text] [Related]
2. Various authentic chemoattractants mediating leukocyte adherence inhibition.
Thomson DM
J Natl Cancer Inst; 1984 Sep; 73(3):595-605. PubMed ID: 6088878
[TBL] [Abstract][Full Text] [Related]
3. Reversible abnormal nonadherence to glass and responsiveness to chemoattractants of leukocytes from patients with advanced cancer.
Thomson DM
J Natl Cancer Inst; 1984 Sep; 73(3):607-16. PubMed ID: 6088879
[TBL] [Abstract][Full Text] [Related]
4. Evidence in advanced cancer of an activated leukocyte state to explain the reversible defect in transmembrane signaling and leukocyte adherence inhibition to extracts of cancer.
Shenouda G; Thomson DM
Clin Immunol Immunopathol; 1984 Aug; 32(2):212-23. PubMed ID: 6375921
[TBL] [Abstract][Full Text] [Related]
5. Transmembrane signal defect and absence of cancer extract induced leukocyte adherence inhibition (LAI) for leukocytes from patients with advanced cancer.
Shenouda G; Thomson DM
Cancer Immunol Immunother; 1984; 18(1):59-68. PubMed ID: 6333270
[TBL] [Abstract][Full Text] [Related]
6. Modulation of antigen-induced leukocyte adherence inhibition by metabolites of arachidonic acid and intracellular nucleotides.
Thomson DM; Phelan K; Scanzano R; Fink A
Int J Cancer; 1982 Sep; 30(3):311-9. PubMed ID: 6752047
[TBL] [Abstract][Full Text] [Related]
7. An overview: antitumor immunity in breast cancer assayed by tube leukocyte adherence inhibition.
Flores M; Marti JH; Grosser N; MacFarlane JK; Thomson DM
Cancer; 1977 Feb; 39(2):494-505. PubMed ID: 319891
[TBL] [Abstract][Full Text] [Related]
8. Requirement for autologous cancer extracts and lipoxygenation of arachidonic acid for human T-cell responses in leukocyte adherence inhibition and transmembrane potential change assays.
Shenouda G; Thomson DM; MacFarlane JK
Cancer Res; 1984 Mar; 44(3):1238-45. PubMed ID: 6420056
[TBL] [Abstract][Full Text] [Related]
9. Leukocyte adherence inhibition (LAI) for detecting specific tumor immunity in colorectal cancer.
Fink A; Shani A; Weisman Z; Wechsler U; Pfeffermann R; Harpaz N; Eitan S; Bentwich Z
Immunol Lett; 1985; 9(2-3):143-7. PubMed ID: 3886534
[TBL] [Abstract][Full Text] [Related]
10. Comparison by leukocyte adherence inhibition of human immune response to cancer-associated immunogens, Thomsen-Friedenreich (T) and Tn, myelin basic protein, and organ-specific cancer neoantigens.
Thomson DM; Springer GF; Desai PR; Scanzano R; Gubersky M; Shenouda G
Clin Immunol Immunopathol; 1988 Nov; 49(2):231-41. PubMed ID: 2458874
[TBL] [Abstract][Full Text] [Related]
11. Regulation of leukocyte glass adherence and tube leukocyte adherence inhibition (LAI) reactivity by serum factors in dogs with progressing or spontaneously regressing canine transmissible venereal sarcoma (CTVS).
Harding MW; Yang TJ
Cancer Immunol Immunother; 1985; 19(3):168-76. PubMed ID: 3891077
[TBL] [Abstract][Full Text] [Related]
12. A study of the immune response to the organ-specific neoantigen of human bladder cancer.
Lajzerowicz M; Thomson DM; Reid EC
J Urol; 1982 Nov; 128(5):1122-9. PubMed ID: 6960193
[TBL] [Abstract][Full Text] [Related]
13. Selective inhibition of leukocyte adherence in women with breast cancer using a variety of tissue extracts.
Fritze D; Kaufmann M; Drings P; Fedra G
Oncology; 1978; 35(6):242-5. PubMed ID: 370704
[TBL] [Abstract][Full Text] [Related]
14. Tube leukocyte adherence inhibition (LAI) assay in gastrointestinal (GIT) cancer.
Tataryn DN; MacFarlane JK; Murray D; Thomson DM
Cancer; 1979 Mar; 43(3):898-912. PubMed ID: 371789
[TBL] [Abstract][Full Text] [Related]
15. Immune responses in lung cancer patients measured by a modified leukocyte adherence inhibition test using serum.
Sanner T; Kotlar HK; Eker P
Cancer Lett; 1980 Feb; 8(4):283-90. PubMed ID: 6989487
[TBL] [Abstract][Full Text] [Related]
16. Mechanism of the LAI test in bladder cancer patients.
Mori K; Toshiaki S; Yamagiwa K; Ohkawa T
J Urol; 1986 Apr; 135(4):856-61. PubMed ID: 3959218
[TBL] [Abstract][Full Text] [Related]
17. Leukocyte adherence inhibition (LAI) in rats bearing transplantable syngeneic tumors of different immunogenicity.
Tank B; Marquet RL; Vennemans E; Westbroek DL
Eur J Cancer Clin Oncol; 1985 Dec; 21(12):1539-46. PubMed ID: 3913605
[TBL] [Abstract][Full Text] [Related]
18. Dimethylsulfoxide prevents chemoattractant-induced leukocyte adherence.
Sekizuka E; Benoit JN; Grisham MB; Granger DN
Am J Physiol; 1989 Feb; 256(2 Pt 2):H594-7. PubMed ID: 2537035
[TBL] [Abstract][Full Text] [Related]
19. A leukocyte adherence inhibition (LAI) assay of anti-tumor immunity in rats using selective radioimmunological assessment of adherence of T lymphocytes and monocytes.
Morizane T; Sjögren HO
Int J Cancer; 1983 Jun; 31(6):803-12. PubMed ID: 6345408
[TBL] [Abstract][Full Text] [Related]
20. Tube leukocyte (monocyte) adherence inhibition assay for the detection of anti-tumour immunity. III. "Blockade" of monocyte reactivity by excess free antigen and immune complexes in advanced cancer patients.
Grosser N; Thompson DM
Int J Cancer; 1976 Jul; 18(1):58-66. PubMed ID: 59711
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
